SalaryGuide
AboutPricingFor Employers

Marketing jobs

6 marketing jobs

Otsuka Pharmaceutical Co., Ltd. logo
1 day ago

Director, Brand Insights - Rare Metabolic

Otsuka Pharmaceutical Co., Ltd.

USA (Remote)Full time$186K/yr – $279K/yr
Otsuka Pharmaceutical Co., Ltd. logo
7 days ago

Director, Marketing Excellence & Development

Otsuka Pharmaceutical Co., Ltd.

USA (Remote)Full time$186K/yr – $279K/yr
Otsuka Pharmaceutical Co., Ltd. logo
8 days ago

Director, Market Access Strategy and Payer Marketing, CNS

Otsuka Pharmaceutical Co., Ltd.

USA (Remote)Full time$186K/yr – $279K/yr
Otsuka Pharmaceutical Co., Ltd. logo
2 weeks ago

Senior Manager, Brand Insights

Otsuka Pharmaceutical Co., Ltd.

Princeton, NJ (Hybrid)Full time$150K/yr – $224K/yr
Otsuka Pharmaceutical Co., Ltd. logo
5 weeks ago

Senior Director, Marketing - Rare Neurology

Otsuka Pharmaceutical Co., Ltd.

USA (Remote)Full time$231K/yr – $345K/yr
Otsuka Pharmaceutical Co., Ltd. logo
6 months ago

Senior Manager, Professional/HCP Marketing, Rare Disease

Otsuka Pharmaceutical Co., Ltd.

Princeton, NJ (On-site)Full time$150K/yr – $224K/yr

All marketing roles in the US

Get alerts for this search

All marketing roles in the US

Get alerts for this search

6 jobs
Otsuka Pharmaceutical Co., Ltd. logo

Director, Brand Insights - Rare Metabolic

Otsuka Pharmaceutical Co., Ltd.

USA (Remote)

$186K/yr - $279K/yrIn-houseFull-timeDirector/executive10+ years exp.
1 day ago
Otsuka Pharmaceutical Co., Ltd. logo

Director, Marketing Excellence & Development

Otsuka Pharmaceutical Co., Ltd.

USA (Remote)

$186K/yr - $279K/yrIn-houseFull-timeDirector/executive8+ years exp.
7 days ago
Otsuka Pharmaceutical Co., Ltd. logo

Director, Market Access Strategy and Payer Marketing, CNS

Otsuka Pharmaceutical Co., Ltd.

USA (Remote)

$186K/yr - $279K/yrIn-houseFull-timeDirector/executive8+ years exp.
8 days ago
Otsuka Pharmaceutical Co., Ltd. logo

Senior Manager, Brand Insights

Otsuka Pharmaceutical Co., Ltd.

Princeton, NJ (Hybrid)

$150K/yr - $224K/yrIn-houseFull-timeSenior level7+ years exp.
2 weeks ago
Otsuka Pharmaceutical Co., Ltd. logo

Senior Director, Marketing - Rare Neurology

Otsuka Pharmaceutical Co., Ltd.

USA (Remote)

$231K/yr - $345K/yrIn-houseFull-timeSenior level12+ years exp.
5 weeks ago
Otsuka Pharmaceutical Co., Ltd. logo

Senior Manager, Professional/HCP Marketing, Rare Disease

Otsuka Pharmaceutical Co., Ltd.

Princeton, NJ (On-site)

$150K/yr - $224K/yrIn-houseFull-timeSenior level3+ years exp.
6 months ago
Otsuka Pharmaceutical Co., Ltd. logo
Otsuka Pharmaceutical Co., Ltd.

Director, Brand Insights - Rare Metabolic

USA (Remote)

$186K/yr – $279K/yrDirector/Executive10+ years expFull time

Posted 1 day ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own and drive the insight program for a rare asset, leading market research, competitive intelligence, and analytics across launch and inline phases in the US.

  • Shape actionable insights that influence brand decisions and address patient/customer needs
  • Develop and own the asset insight plan and budget, coordinating with key stakeholders

Job Description

Responsibilities

  • The Director Brand Insights position is responsible for leading the primary market research, competitive intelligence, and business analytics for the relevant rare asset, with a particular focus on launch preparation.
  • The Director, Brand Insights is expected to function as a player/coach and contribute to the design and implementation of actionable insights generation that influences business decisions that add value, address patient/customer needs, and that drive brand performance in the US.
  • Additionally, the Director, Brand Insights is expected to develop and own the insight plan for the relevant asset while managing the related budget and resources to drive execution.
  • The primary stakeholders for the Director, Brand Insights, include the relevant asset brand team, Market Access Marketing, Field Enablement, Sales, Medical Affairs, Field Enablement and Global.

Requirements

  • Minimum of 10 years’ progressive experience in customer insights and analytics in the pharmaceutical industry or related profession.
  • Rare disease experience is critical. Experience in immunology, neurology, nephrology, oncology a plus.
  • Experience driving insights in both the launch and inline phase in the United States
  • Minimum of 3 years leading a team
  • Bachelor’s degree in business, Statistics, Economics, Life Sciences, Computer Science, or a related field.

Benefits

  • Company benefits: Comprehensive medical, dental, vision, prescription drug coverage, company provided basic life, accidental death & dismemberment, short-term and long-term disability insurance, tuition reimbursement, student loan assistance, a generous 401(k) match, flexible time off, paid holidays, and paid leave programs as well as other company provided benefits.
Otsuka Pharmaceutical Co., Ltd. logo

Otsuka Pharmaceutical Co., Ltd.

2-9, Kanda-Tsukasamachi, Chiyoda-ku, Tokyo 101-8535, Japan

Chiyoda, Tokyo, Japan
892 employees (45 in marketing)
www.otsuka.co.jp

Traffic Signals

Monthly Visitors
1.1M
Traffic Source Mix
Search
78.6%
Direct
16%
Referral
4%
Social
0.6%
Paid
0.7%

Headcount Trend

Current headcount: ~894

Marketing Team

Marketing Team Size
45 (5% of company)
Marketing Roles Posted (Last 30 Days)
4

Recent News

Rxulti now approved for adolescents in Europe
Mar 13, 2025 • Pharma Letter
Vitamins and Supplements Market Size to Worth USD 250.81 Billion by 2032 | CAGR of 6.20% during 2024-2032
Mar 12, 2025 • EIN Presswire
Obsessive Compulsive Disorder Global Market Report 2025: A Comprehensive Analysis And Forecast
Mar 5, 2025 • EIN Presswire
Fitness Nutrition Drinks Market Size 2025 Advanced Technologies and Growth Opportunities, SWOT Analysis in Industry 2033
Mar 5, 2025 • EIN Presswire
Global Schizophrenia Drugs Market Forecast 2025-2034: Analyzing Growth Drivers, Market Share, Segments, Emerging Trends
Feb 27, 2025 • EIN Presswire
Parkinson’s Disease Psychosis Market Size to Reach USD 694.3 Million by 2035, Impelled by Advancements in Personalized Medicine
Feb 7, 2025 • BioSpace
Post-Traumatic Stress Disorder Treatment Projected to Reach USD 22.85 Billion by 2032, Growing at a CAGR of 4.81%
Jan 24, 2025 • EIN Presswire
Digital Therapeutics Market Will Surpass US$ 70.63 Billion at 29.5% CAGR Growth Forecasted By 2032
Jan 16, 2025 • EIN Presswire
Otsuka and Ionis’ donidalorsen accepted for EMA review
Jan 6, 2025 • Pharma Letter
Autosomal Dominant Polycystic Kidney Disease Market to Grow Positively at a Paltry CAGR During the Study Period
Dec 17, 2024 • EIN Presswire
Otsuka Submits New Drug Application in Japan for Bempedoic Acid in the Treatment of Hypercholesterolemia
Nov 26, 2024 • GlobeNewswire News Room
Esperion Therapeutics (ESPR): Otsuka Submits New Drug Application in Japan for Bempedoic Acid in the Treatment of Hypercholesterolemia
Nov 26, 2024 • StreetInsider.com
Gastroparesis Drugs Market to Grow by USD 1.42 Billion from 2024-2028, Driven by Rising Diabetes Rates and AI-Driven Market Trend Insights - Technavio
Nov 5, 2024 • PR Newswire
2024 Research: Pediatric Drugs Market Poised for Robust Growth, Projected at 4.79% CAGR Through 2030
Nov 1, 2024 • GlobeNewswire News Room
Japan to see price hikes for 282 food products this month
Oct 31, 2024 • The Japan Times
Japan's Otsuka Pharma to pay up to $1.1 bln to acquire Jnana Therapeutics
Aug 1, 2024 • Reuters
Ionis announces expanded licensing agreement with Otsuka in Asia Pacific for investigational medicine donidalorsen in hereditary angioedema
Jul 2, 2024 • PR Newswire
Ionis (IONS) Expands Licensing Deal With Otsuka for HAE Drug
Jun 21, 2024 • Yahoo Finance
Japan's Otsuka to stop development of Alzheimer's disease drug
May 28, 2024 • Reuters
Schizophrenia Drugs Market Forecasted to Grow at 5.6% CAGR Through 2032
May 28, 2024 • PharmiWeb.com
Antipsychotic Drugs Market Size to Capture USD 37.40 Billion by 2032
May 28, 2024 • BioSpace
Otsuka pulls plug on Alzheimer's agitation drug after 2nd failed trial
May 22, 2024 • FiercePharma
Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic
Apr 1, 2024 • STAT